Current Collaborators

Current Glo-BNHL treatment arms:

Bispecific antibody Odronextamab, Regeneron Pharmaceuticals Inc.

Antibody Drug Conjugate Loncastuximab tesirine with standard chemotherapy, ADC Therapeutics SA